Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol anesthesia and recovery across different body surface areas in thoracic pulmonary lobectomy
ChiCTR2300078969Phase 3Not yet recruiting
- Sponsor
- The Second Affiliated Hospital of Dalian Medical University
- Start
- Dec 2023
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of ciprofol in None (3 arms), sponsored by The Second Affiliated Hospital of Dalian Medical University. Primary endpoints: Ciprofol metabolic time, Awakening time and 1 more. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
ciprofol
Beyond the preview
Go deeper on ChiCTR2300078969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078969.